Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

tumor or ulcers News

  + XML/RSS  



By SMi Group
Consider novel linker strategy techniques to increase efficacy of ADC products

By Austin Dentist
Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays

By Caring for Carcinoid Foundation
The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

By National Canine Cancer Foundation
Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

By Melanie Bernds
Collaboration with the Stanley lab shows that there are natural compounds from plants that can control this deadly disorder and, with the atomic structure in hand, can be used as a starting point for further drug design.

By Central Park Communications
Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

All Press Releases

By SMi Group
Consider novel linker strategy techniques to increase efficacy of ADC products

By Austin Dentist
Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays

By Harrison Edwards PR
Charity Outing Will Support Foundation’s Leading Edge Brain Cancer Research & Clinical Trials in the Greater New York Metropolitan Area - One Lucky Golfer Who Hits a Hole-in-One Will Win a New Porsche 911 Carrera, Courtesy of Pepe Porsche

By SMi Group
Characterisaion of ADC's is a crtitical step for both research and development of efficacious and safe therapeutics

By Caring for Carcinoid Foundation
The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

By Caring for Carcinoid Foundation
The Caring for Carcinoid Foundation (CFCF) is pleased to announce its celebratory programming in honor of Worldwide NET Cancer Awareness Day. CFCF-sponsored events include a Patient Education Seminar and awarding grants to patient support groups.

By National Canine Cancer Foundation
Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

By Melanie Bernds
Collaboration with the Stanley lab shows that there are natural compounds from plants that can control this deadly disorder and, with the atomic structure in hand, can be used as a starting point for further drug design.

By J.P.L. Postmes
Doctor Pereira Albino (vascular surgeon) wrote a case report titled: “Recurrent ulcers in a patient with post-thrombotic syndrome." This was published in the latest Wounds UK Journal (Vol.7, No.2).

By Central Park Communications
Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

By Fast Market Research
New Medical Devices research report from GlobalData is now available from Fast Market Research

By Frank Groff Inc.
Surgeon to Remove Potentially Deadly Tumor near Brainstem

By Binghamton University
Many new cancer weapons come as personalized therapies that can target specific changes in an individual’s tumor. Leading the work are Binghamton University researchers who are using a new tool in studying tubulin tyrosine ligase, or TTL enzyme.

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By Elegance Vie Corp.
Immunolizer® is a natural formula scientifically designed to optimize the immune system's performance. Immunolizer® activates the body's defense mechanisms and helps the Immune System to distinguish adequately between self and non-self.

By Fast Market Research
Recently published research from GlobalData, "Brain Tumor - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

By Innovative Medical Products
TUFFease® gel’s new outer cover reduces friction with the patient’s skin, is less prone to tearing, easier to clean and is environmentally friendly

By Adrian Newman
D” stands for diarrhea. It’s an unpleasant subject, but one that is frustratingly common and hits close to home for the vast majority of us.

By Shridhar University
As the Guinness Record holder for operating a 66kg tumor, Dr Makeshwari takes his inspiration from Apple CEO Steve Jobs quote "Innovation distinguishes between a leader and follower."

By South Nassau Communities Hospital
The study revealed that when the loss of heterozygosity (LOH) was identical (concordant) in the tumors they were metastatic. New multifocal primary cancers had discordant LOH, meaning their LOH was not identical.

By Jeffrey S. Musmacher
Several milestones achieved following its first year treating patients in Suffolk County, New York.

By Crosspointe Media, Inc.
“While I was sitting in the 'chemo room' with the transparent fluid dripping into my right arm---I wish I'd had a book like Chemo Club to read” said Louise Moeri, author of Chemo Club, published by Crosspointe Media, Inc. in Modesto, CA.

By pankaj nagpal
A brain tumor is an abnormal growth of cells within the brain, which can be cancerous or non-cancerous (benign).

By Bharatbook
Avastin (bevacizumab; Genentech/Roche/Chugai) is a humanized monoclonal antibody directed towards vascular endothelial growth factor (VEGF). VEGF plays an important role in angiogenesis, a key driver of tumor growth.

By pankaj nagpal
Radiotherapy is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

By Fleming Gulf
MENA Oncology conference is being organized as a result of the increasing incidences and heightened fear of this disease, will provide information and discuss latest technological developments in the treatment of breast cancer.

By Scott Isaacs, ND, DC
Are you suffering from the ravages of ulcerative colitis? Are you looking for a better way to become healthier and escape the pain? Read on for more information about a safe, effective, and natural therapy for ulcerative colitis!

By A. Schulz
Visualase Inc. Selected to Present at Epilepsy Conference Highlighting New and Promising Epilepsy Therapies. Epilepsy Pipeline Update 2010 to Take Place February 25-26 in San Francisco.

By reports-research.com
The new Business Insights report Cancer Market Outlook to 2014: Competitive landscape, market size, pipeline analysis and growth opportunities looks into what the future holds for players in the fastest growing pharmaceutical market.

By Andres Schulz
Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The precision and control of the Visualase technology has made possible the ablation of tissue in areas such as brain and prostate.

By Natural Energy Products
Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body

By Natural Energy Products
Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body.

By Energetix Corporation
DGL Gut Complex – Mucosal Support for a Healthy Immune System

By Ambassadorial Society of America
Venus Day Has Been Recognized for her Volunteer Work by Jeb Bush, the Governor of Florida as a Point of Light Award Recipient

By Wiseman Research Initiatives LLC
A study to develop a new genetically engineered vaccine opened officially Oct 16. The program has begun screening patients. Initial clinical trial reported rapid shrinkage and/or disappearance of widespread tumors within eight weeks.

By markmillermusic.org
Glioblastoma patient using experimental vaccine consisting of his own brain tumor tissue and white blood cells showing results

By College Station Medical Center
A new, robotic-assisted minimally invasive thyroid surgery can now offer those with thyroid tumors relief without neck scars. This new procedure is being performed using the daVinci® Surgical System at College Station Medical Center in Texas.

By Innovative Medical Products
Innovative Medical Products' softer, lighter, more supple Gel Support Pad aids in prevention of pressure sores. ‘Phase 4™’ Gel pad is coated with an innovative, micro-thin jacket that moves with a patient’s skin to minimize skin shear forces.

By Adriana Vela
--- NanoTecNexus and NanoTumor Center Education Projects Rank High ---

By RNL Bio, Co., Ltd.
Korean-FDA approved RNL’s Astrostem based on patient’s own fat derived stem cells to treat spinal cord injury. Phase I human trial will be done by intravenous infusion of stem cells at Sam Hospital in Anyang, South Korea

By Laparoscopy Hospital
Dr.. R.K. Mishra, holding Master Degree in Mimimal Access has successfully removed a 20-Kg tumour, known as retroperitoneal tumour from the abdomen of a patient.

By Blogging in B Minor
Blogging in B Minor (markmillermusic.org/blog) chronicles Mark Miller's journey as a grade 4 brain tumor survivor and provides other brain tumor survivors with in-depth research information and personal experience to provide hope and encouragement.

By GTCbio
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.

By Anaspec, Inc.
Melanoma, a malignant tumor that arises in melanocytes, is the most deadly of all skin cancers.



Page:
  • 1



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share